BrainBeats 作为开源 EEGLAB 插件，用于联合分析 EEG 和心血管信号
2024年4月26日
3.9K 次观看
BrainBeats 工具箱是一个开源的 EEGLAB 插件，旨在联合分析 EEG 和心血管 （ECG/PPG） 信号。它包括心跳诱发电位 （HEP） 评估、基于特征的分析以及从 EEG 信号中提取心脏伪影。该协议将有助于通过两个镜头（HEP 和特征）研究脑心相互作用，从而提高可重复性和可及性。
BrainBeats 工具箱的范围是提供一个开源的自动化工具，用于进行脑心相互作用的研究。它允许研究人员通过标准化信号处理、特征提取、图形用户界面和数据可视化对 EEG 和心血管信号进行多模态分析。由于科学中历史上的还原论方法，大脑和心脏系统已经分离和孤立，导致对它们的相互作用和相互影响的理解有限。
BrainBeats 工具箱旨在弥合这一差距。了解大脑和心脏之间的相互作用使研究人员能够更深入地了解认知和情绪状态如何影响心血管功能，反之亦然。反过来，这些见解可以带来新的治疗干预和治疗方法。
概述
BrainBeats工具箱是一个开源EEGLAB插件，旨在促进EEG和心血管（ECG/PPG）信号的联合分析。该工具箱通过提供心跳诱发电位（HEP）评估和EEG信号中心脏伪影提取的工具来增强对脑心相互作用的研究，最终提高研究的可重复性和可访问性。
关键研究组成部分
科学领域
- 神经科学
- 心血管研究
- 信号处理
背景
- 历史上，大脑和心脏系统被分别研究，限制了对它们相互作用的理解。
- BrainBeats工具箱通过允许研究人员探索这些系统之间的动态相互作用来解决这一差距。
- 对认知和情感状态对心血管功能影响的洞察可以导致新的治疗干预。
研究目的
- 提供EEG和心血管信号多模态分析的标准化工具。
- 增强对脑心相互作用及其对心理和身体健康影响的理解。
- 提高相关研究的可访问性和可重复性。
使用的方法
- 该研究在MATLAB上使用EEGLAB框架内的BrainBeats工具箱。
- 通过图形界面分析EEG和心血管信号（包括ECG和PPG）以评估HEP和心脏伪影。
- 该协议包括在MATLAB中设置路径、加载数据集和执行特征提取。
- 关键步骤包括更改电源线噪声设置并在整个分析过程中验证输出。
主要结果
- 显著发现包括心跳后α波段的显著心跳诱发振荡。
- 试间相干性分析表明EEG相位与心跳之间没有显著的相位锁定。
- 关键输出还包括HRV特征和EEG数据，揭示了与心脏节律相关的重要模式。
结论
- BrainBeats工具箱展示了在大脑和心脏研究之间建立桥梁的潜力。
- 它使得对认知和情感对心血管健康影响的理解更加全面。
- 获得的洞察可以为未来的治疗策略和干预措施提供信息。
常见问题
BrainBeats工具箱有哪些优势？
它提供了一个开源平台，用于EEG和心血管信号的集成分析，提高了研究的可重复性和可访问性。
研究人员如何实施BrainBeats工具箱？
研究人员使用MATLAB来设置工具，加载EEG和心血管数据集，并通过用户友好的GUI进行分析。
使用这种方法可以获得哪些类型的结果？
该方法允许从EEG中提取心跳诱发电位、心脏伪影分析和心率变异性特征。
BrainBeats工具箱可以适用于不同的研究吗？
可以，它可用于研究脑心相互作用的各个方面，并可根据不同的数据集和研究问题进行定制。
BrainBeats工具箱的主要局限性是什么？
潜在的局限性包括对数据质量的依赖以及研究人员需要熟悉MATLAB和EEGLAB。
Executive Industry Relevance
Integrating EEG and cardiovascular signal analysis addresses a critical gap in early discovery by enabling standardized, multimodal interrogation of brain-heart interplay. The BrainBeats toolbox enhances predictive confidence in neurocardiac biomarker research and supports robust feature extraction for translational and preclinical studies. This capability is strategically positioned to improve reproducibility, data quality, and cross-functional R&D workflows in biopharma pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables mechanistic de-risking by jointly analyzing neural and cardiovascular signals for target validation.
- Supports hypothesis-driven exploration of brain-heart interactions relevant to neurocardiac disease models.
- Facilitates extraction of quantitative features for pathway clarification and functional biomarker identification.
Screening & Assay Development
- Standardizes EEG and HRV feature extraction to improve assay reproducibility and downstream screening reliability.
- Automates artifact removal, ensuring clean datasets for high-throughput compound evaluation.
- Prepares validated multimodal datasets for scalable machine learning model development.
Translational & Preclinical Research
- Aligns extracted features with disease-relevant neurocardiac biomarkers for translational continuity.
- Enables risk-adjusted advancement decisions by providing robust, reproducible readouts across preclinical models.
- Supports cross-system mechanistic studies to inform therapeutic hypothesis refinement.
Pipeline & Workflow Integration
The BrainBeats plugin fits within the discovery-to-preclinical continuum by enabling standardized, multimodal data integration and analysis.
- Discovery Biology: Facilitates null hypothesis testing and pathway interrogation through synchronized EEG and cardiovascular signal analysis.
- Screening: Provides reproducible, quantitative outputs for assay development and compound triage.
- Analytics: Delivers feature-rich datasets and statistical outputs for robust condition comparison and model training.
- Translational Research: Bridges discovery and preclinical phases by aligning neurocardiac features with disease models.
- Enterprise Reuse: Offers an open-source, GUI-driven platform adaptable across diverse R&D programs and datasets.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in neurocardiac research.
- Operational Value: Enhances standardization, reproducibility, and scalability of multimodal signal analysis.
- Strategic Value: Improves go/no-go decision quality and capital efficiency by enabling robust biomarker discovery.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of neurocardiac targets and models.
Implementation Considerations
- Requires expertise in EEG, cardiovascular signal processing, and MATLAB/EEGLAB environments.
- Depends on access to high-quality, synchronized EEG and ECG/PPG datasets.
- Necessitates cross-team agreement on feature extraction and artifact removal standards.
- Adaptable to various model systems but may require parameter tuning for optimal results.
- Data quality and signal integrity directly impact analysis reliability and downstream utility.
Biopharma FAQs
Why does null hypothesis testing of HEP outputs matter for target validation?
Null hypothesis testing of heartbeat-evoked potential (HEP) outputs enables objective assessment of brain-heart interactions, supporting mechanistic de-risking and increasing confidence in neurocardiac target validation decisions.
How does independent variable isolation in EEG/HRV feature extraction fit the discovery pipeline?
Isolating independent variables during EEG and HRV feature extraction allows researchers to attribute observed effects to specific interventions or conditions, strengthening the interpretability and reliability of early discovery findings.
What do quantitative dependent variable measurements from BrainBeats enable?
Quantitative measurements of EEG and HRV features provide standardized, reproducible outputs that facilitate robust comparison across experimental conditions and support downstream machine learning model development.
Why are replication requirements for artifact removal critical for cross-functional teams?
Replication of automated heart artifact removal ensures data integrity and reproducibility, enabling consistent results across teams and supporting collaborative assay development and validation efforts.
What statistical analysis capabilities are required before implementing multimodal EEG-cardiovascular workflows?
Robust statistical analysis, including coherence and spectral feature extraction, is essential to validate findings and ensure that multimodal EEG-cardiovascular workflows yield actionable, reproducible insights for R&D decision-making.
